Portfolio Company Spotlight: Alderley Lighthouse Labs

Seneca Growth Capital VCT invested £500k into Alderley Lighthouse Labs (“ALL”) in October 2022.

ALL is a new diagnostics company, set up by two of the leadership team that built the Alderley Park COVID screening laboratory. They have captured many learnings from the pandemic and invested in the latest technologies to offer high quality testing that can be seamlessly integrated with modern IT systems. The company offers services that cover both blood sciences and molecular testing across a broad range of diagnostics including, blood biomarker testing, full blood count, health and fitness markers, diabetes, cancer, infection etc. The laboratory is fully accredited with UKAS to their 15189 standard.

Watch the ALL video on LinkedIn to find out more.

Important notice

The contents of this website are a financial promotion and are approved by Seneca Partners Limited of 9 The Parks, Newton-le-Willows WA12 0JQ.

The value of an investment in the Seneca Capital Growth VCT plc may go down as well as up, in which case an investor may not get back the amount invested. The share prices quoted may not reflect the VCT’s net asset value.

Seneca Growth Capital VCT plc’s investments include holdings in private companies which are small and which carry an above-average level of risk to capital and whose shares may not be readily marketable. It also invests in companies quoted on the Alternative Investment Market (AIM) of the London Stock Exchange (LSE) which is generally for smaller, emerging companies and carries a higher level of risk to capital than the main market of the LSE.  The past performance of Seneca Growth Capital VCT plc is not a guide to the future performance.

Any tax reliefs available to investors are dependent on personal circumstances and may change in the future. The tax reliefs available to certain investors in Seneca Growth Capital VCT plc are dependent on the VCT maintaining Inland Revenue approval. If this approval is withdrawn, the VCT will lose its status and all tax reliefs are likely to be cancelled. Investors must retain their VCT shares for five years to retain the up-front income tax relief. The tax rules and regulations governing VCTs are subject to change.

An investment in Seneca Growth Capital VCT plc may not be suitable for all investors. Investors should seek advice from a qualified financial adviser. Nothing on this website should be construed as investment or tax advice.

Seneca Partners Ltd is authorised and regulated by the Financial Conduct Authority.